We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer

News   Apr 06, 2009

 
Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
 
 
 

RELATED ARTICLES

Drug Testing Fingerprints Could Differentiate Heroine Users From Handlers

News

Fingerprint detection technology can now identify traces of heroin on human skin, even after someone has washed their hands.

READ MORE

Orangutan Connected Directly to Extinct Giant Ape

News

Researchers have successfully reconstructed the evolutionary relationship between a two million year old giant primate and the living orangutan.

READ MORE

Screening System Designed To Detect Drugs That Block Drivers of Cancer Cell Growth

News

A new screening system leverages redundancy in an important component of a cell – nucleotide metabolism – to help detect new drugs that specifically and potently block processes that are essential for cancer cell growth.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE